Global Diabetes Devices Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 16-Nov-2022
No. of pages: 114
Inquire Before Buying

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Diabetes Devices manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Diabetes Devices market. Further, it explains the major drivers and regional dynamics of the global Diabetes Devices market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Medtronic

- Sanofi

- Bayer

- Becton

- Dickinson and Company

- Novo Nordisk

- Abbott Laboratories

- Roche

- Lifescan

- B. Braun

- Dexcom

- Ypsomed Holdings

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Diabetes Devices Segment by Type

- Blood Glucose Monitoring (BGM) Devices

- Insulin Delivery Devices

Diabetes Devices Segment by Application

- Hospital

- Personal Use

- Clinic

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Diabetes Devices market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Diabetes Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Diabetes Devices, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Diabetes Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diabetes Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Diabetes Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Diabetes Devices sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Medtronic, Sanofi, Bayer, Becton, Dickinson and Company, Novo Nordisk, Abbott Laboratories, Roche and Lifescan, etc.

Global Diabetes Devices Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Diabetes Devices Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Blood Glucose Monitoring (BGM) Devices
1.2.3 Insulin Delivery Devices
1.3 Market Segment by Application
1.3.1 Global Diabetes Devices Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Personal Use
1.3.4 Clinic
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Diabetes Devices Market Size (2017-2028)
2.1.1 Global Diabetes Devices Revenue (2017-2028)
2.1.2 Global Diabetes Devices Sales (2017-2028)
2.2 Global Diabetes Devices Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Diabetes Devices Sales by Regions (2017-2022)
2.2.2 Global Diabetes Devices Revenue by Regions (2017-2022)
2.3 Global Diabetes Devices Market Size Forecast by Region
2.3.1 Global Diabetes Devices Sales Forecast by Region (2023-2028)
2.3.2 Global Diabetes Devices Revenue Forecast by Region (2023-2028)
2.4 Global Top Diabetes Devices Regions (Countries) Ranking by Market Size
2.5 Diabetes Devices Market Dynamics
2.5.1 Diabetes Devices Market Trends
2.5.2 Diabetes Devices Market Drivers
2.5.3 Diabetes Devices Market Challenges
2.5.4 Diabetes Devices Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Diabetes Devices Manufacturers by Sales (2017-2022)
3.1.1 Global Diabetes Devices Sales by Manufacturers (2017-2022)
3.1.2 Global Diabetes Devices Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Diabetes Devices Sales in 2021
3.2 Global Top Manufacturers Diabetes Devices by Revenue
3.2.1 Global Diabetes Devices Revenue by Manufacturers (2017-2022)
3.2.2 Top Diabetes Devices Manufacturers Covered: Ranking by Revenue
3.2.3 Global Diabetes Devices Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Diabetes Devices Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diabetes Devices as of 2021)
3.4 Global Diabetes Devices Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Diabetes Devices Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Diabetes Devices Market
3.7 Key Manufacturers Diabetes Devices Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Diabetes Devices Market Size by Type
4.1 Global Diabetes Devices Historic Market Review by Type (2017-2022)
4.1.1 Global Diabetes Devices Sales Market Share by Type (2017-2022)
4.1.2 Global Diabetes Devices Revenue Market Share by Type (2017-2022)
4.1.3 Diabetes Devices Price by Type (2017-2022)
4.2 Global Diabetes Devices Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Diabetes Devices Sales Forecast by Type (2023-2028)
4.2.2 Global Diabetes Devices Revenue Forecast by Type (2023-2028)
4.2.3 Diabetes Devices Price Forecast by Type (2023-2028)
5 Global Diabetes Devices Market Size by Application
5.1 Global Diabetes Devices Historic Market Review by Application (2017-2022)
5.1.1 Global Diabetes Devices Sales Market Share by Application (2017-2022)
5.1.2 Global Diabetes Devices Revenue Market Share by Application (2017-2022)
5.1.3 Diabetes Devices Price by Application (2017-2022)
5.2 Global Diabetes Devices Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Diabetes Devices Sales Forecast by Application (2023-2028)
5.2.2 Global Diabetes Devices Revenue Forecast by Application (2023-2028)
5.2.3 Diabetes Devices Price Forecast by Application (2023-2028)
6 North America
6.1 North America Diabetes Devices Sales Breakdown by Company
6.1.1 North America Diabetes Devices Sales by Company (2017-2022)
6.1.2 North America Diabetes Devices Revenue by Company (2017-2022)
6.2 North America Diabetes Devices Market Size by Type
6.2.1 North America Diabetes Devices Sales by Type (2017-2028)
6.2.2 North America Diabetes Devices Revenue by Type (2017-2028)
6.3 North America Diabetes Devices Market Size by Application
6.3.1 North America Diabetes Devices Sales by Application (2017-2028)
6.3.2 North America Diabetes Devices Revenue by Application (2017-2028)
6.4 North America Diabetes Devices Market Size by Country
6.4.1 North America Diabetes Devices Sales by Country (2017-2028)
6.4.2 North America Diabetes Devices Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Diabetes Devices Sales Breakdown by Company
7.1.1 Europe Diabetes Devices Sales by Company (2017-2022)
7.1.2 Europe Diabetes Devices Revenue by Company (2017-2022)
7.2 Europe Diabetes Devices Market Size by Type
7.2.1 Europe Diabetes Devices Sales by Type (2017-2028)
7.2.2 Europe Diabetes Devices Revenue by Type (2017-2028)
7.3 Europe Diabetes Devices Market Size by Application
7.3.1 Europe Diabetes Devices Sales by Application (2017-2028)
7.3.2 Europe Diabetes Devices Revenue by Application (2017-2028)
7.4 Europe Diabetes Devices Market Size by Country
7.4.1 Europe Diabetes Devices Sales by Country (2017-2028)
7.4.2 Europe Diabetes Devices Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Diabetes Devices Sales Breakdown by Company
8.1.1 Asia Pacific Diabetes Devices Sales by Company (2017-2022)
8.1.2 Asia Pacific Diabetes Devices Revenue by Company (2017-2022)
8.2 Asia Pacific Diabetes Devices Market Size by Type
8.2.1 Asia Pacific Diabetes Devices Sales by Type (2017-2028)
8.2.2 Asia Pacific Diabetes Devices Revenue by Type (2017-2028)
8.3 Asia Pacific Diabetes Devices Market Size by Application
8.3.1 Asia Pacific Diabetes Devices Sales by Application (2017-2028)
8.3.2 Asia Pacific Diabetes Devices Revenue by Application (2017-2028)
8.4 Asia Pacific Diabetes Devices Market Size by Region
8.4.1 Asia Pacific Diabetes Devices Sales by Region
8.4.2 Asia Pacific Diabetes Devices Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Diabetes Devices Sales Breakdown by Company
9.1.1 Latin America Diabetes Devices Sales by Company (2017-2022)
9.1.2 Latin America Diabetes Devices Revenue by Company (2017-2022)
9.2 Latin America Diabetes Devices Market Size by Type
9.2.1 Latin America Diabetes Devices Sales by Type (2017-2028)
9.2.2 Latin America Diabetes Devices Revenue by Type (2017-2028)
9.3 Latin America Diabetes Devices Market Size by Application
9.3.1 Latin America Diabetes Devices Sales by Application (2017-2028)
9.3.2 Latin America Diabetes Devices Revenue by Application (2017-2028)
9.4 Latin America Diabetes Devices Market Size by Country
9.4.1 Latin America Diabetes Devices Sales by Country (2017-2028)
9.4.2 Latin America Diabetes Devices Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Diabetes Devices Sales Breakdown by Company
10.1.1 Middle East and Africa Diabetes Devices Sales by Company (2017-2022)
10.1.2 Middle East and Africa Diabetes Devices Revenue by Company (2017-2022)
10.2 Middle East and Africa Diabetes Devices Market Size by Type
10.2.1 Middle East and Africa Diabetes Devices Sales by Type (2017-2028)
10.2.2 Middle East and Africa Diabetes Devices Revenue by Type (2017-2028)
10.3 Middle East and Africa Diabetes Devices Market Size by Application
10.3.1 Middle East and Africa Diabetes Devices Sales by Application (2017-2028)
10.3.2 Middle East and Africa Diabetes Devices Revenue by Application (2017-2028)
10.4 Middle East and Africa Diabetes Devices Market Size by Country
10.4.1 Middle East and Africa Diabetes Devices Sales by Country (2017-2028)
10.4.2 Middle East and Africa Diabetes Devices Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Overview
11.1.3 Medtronic Diabetes Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Medtronic Diabetes Devices Products and Services
11.1.5 Medtronic Diabetes Devices SWOT Analysis
11.1.6 Medtronic Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Diabetes Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Sanofi Diabetes Devices Products and Services
11.2.5 Sanofi Diabetes Devices SWOT Analysis
11.2.6 Sanofi Recent Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Overview
11.3.3 Bayer Diabetes Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Bayer Diabetes Devices Products and Services
11.3.5 Bayer Diabetes Devices SWOT Analysis
11.3.6 Bayer Recent Developments
11.4 Becton
11.4.1 Becton Corporation Information
11.4.2 Becton Overview
11.4.3 Becton Diabetes Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Becton Diabetes Devices Products and Services
11.4.5 Becton Diabetes Devices SWOT Analysis
11.4.6 Becton Recent Developments
11.5 Dickinson and Company
11.5.1 Dickinson and Company Corporation Information
11.5.2 Dickinson and Company Overview
11.5.3 Dickinson and Company Diabetes Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Dickinson and Company Diabetes Devices Products and Services
11.5.5 Dickinson and Company Diabetes Devices SWOT Analysis
11.5.6 Dickinson and Company Recent Developments
11.6 Novo Nordisk
11.6.1 Novo Nordisk Corporation Information
11.6.2 Novo Nordisk Overview
11.6.3 Novo Nordisk Diabetes Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Novo Nordisk Diabetes Devices Products and Services
11.6.5 Novo Nordisk Diabetes Devices SWOT Analysis
11.6.6 Novo Nordisk Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Corporation Information
11.7.2 Abbott Laboratories Overview
11.7.3 Abbott Laboratories Diabetes Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Abbott Laboratories Diabetes Devices Products and Services
11.7.5 Abbott Laboratories Diabetes Devices SWOT Analysis
11.7.6 Abbott Laboratories Recent Developments
11.8 Roche
11.8.1 Roche Corporation Information
11.8.2 Roche Overview
11.8.3 Roche Diabetes Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Roche Diabetes Devices Products and Services
11.8.5 Roche Diabetes Devices SWOT Analysis
11.8.6 Roche Recent Developments
11.9 Lifescan
11.9.1 Lifescan Corporation Information
11.9.2 Lifescan Overview
11.9.3 Lifescan Diabetes Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Lifescan Diabetes Devices Products and Services
11.9.5 Lifescan Diabetes Devices SWOT Analysis
11.9.6 Lifescan Recent Developments
11.10 B. Braun
11.10.1 B. Braun Corporation Information
11.10.2 B. Braun Overview
11.10.3 B. Braun Diabetes Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 B. Braun Diabetes Devices Products and Services
11.10.5 B. Braun Diabetes Devices SWOT Analysis
11.10.6 B. Braun Recent Developments
11.11 Dexcom
11.11.1 Dexcom Corporation Information
11.11.2 Dexcom Overview
11.11.3 Dexcom Diabetes Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Dexcom Diabetes Devices Products and Services
11.11.5 Dexcom Recent Developments
11.12 Ypsomed Holdings
11.12.1 Ypsomed Holdings Corporation Information
11.12.2 Ypsomed Holdings Overview
11.12.3 Ypsomed Holdings Diabetes Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 Ypsomed Holdings Diabetes Devices Products and Services
11.12.5 Ypsomed Holdings Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Diabetes Devices Value Chain Analysis
12.2 Diabetes Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Diabetes Devices Production Mode & Process
12.4 Diabetes Devices Sales and Marketing
12.4.1 Diabetes Devices Sales Channels
12.4.2 Diabetes Devices Distributors
12.5 Diabetes Devices Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Diabetes Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Blood Glucose Monitoring (BGM) Devices
Table 3. Major Manufacturers of Insulin Delivery Devices
Table 4. Global Diabetes Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Diabetes Devices Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Diabetes Devices Sales by Region (2017-2022) & (K Units)
Table 7. Global Diabetes Devices Sales Market Share by Region (2017-2022)
Table 8. Global Diabetes Devices Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Diabetes Devices Revenue Market Share by Region (2017-2022)
Table 10. Global Diabetes Devices Sales Forecast by Region (2023-2028) & (K Units)
Table 11. Global Diabetes Devices Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Diabetes Devices Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Diabetes Devices Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Diabetes Devices Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Diabetes Devices Market Trends
Table 16. Diabetes Devices Market Drivers
Table 17. Diabetes Devices Market Challenges
Table 18. Diabetes Devices Market Restraints
Table 19. Global Diabetes Devices Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Diabetes Devices Sales Share by Manufacturers (2017-2022)
Table 21. Global Diabetes Devices Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Diabetes Devices Manufacturers by Revenue (US$ Million) in 2021
Table 23. Diabetes Devices Revenue Share by Manufacturers (2017-2022)
Table 24. Global Diabetes Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diabetes Devices as of 2021)
Table 26. Key Manufacturers Diabetes Devices Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 27. Key Manufacturers Diabetes Devices Plants/Factories Distribution
Table 28. Key Manufacturers Diabetes Devices Area Served
Table 29. Date of Key Manufacturers Enter into Diabetes Devices Market
Table 30. Key Manufacturers Diabetes Devices Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Diabetes Devices Sales (K Units) by Type (2017-2022)
Table 33. Global Diabetes Devices Sales Share by Type (2017-2022)
Table 34. Global Diabetes Devices Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Diabetes Devices Price (K Units) by Type (2017-2022)
Table 36. Global Diabetes Devices Sales (K Units) by Type (2023-2028)
Table 37. Global Diabetes Devices Sales Share by Type (2023-2028)
Table 38. Global Diabetes Devices Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Diabetes Devices Revenue Share by Type (2023-2028)
Table 40. Global Diabetes Devices Price (K Units) by Type (2023-2028)
Table 41. Global Diabetes Devices Sales (K Units) by Application (2017-2022)
Table 42. Global Diabetes Devices Sales Share by Application (2017-2022)
Table 43. Global Diabetes Devices Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Diabetes Devices Price (K Units) by Application (2017-2022)
Table 45. Global Diabetes Devices Sales (K Units) by Application (2023-2028)
Table 46. Global Diabetes Devices Sales Share by Application (2023-2028)
Table 47. Global Diabetes Devices Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Diabetes Devices Revenue Share by Application (2023-2028)
Table 49. Global Diabetes Devices Price (K Units) by Application (2023-2028)
Table 50. North America Diabetes Devices Sales by Company (2017-2022) & (K Units)
Table 51. North America Diabetes Devices Sales Market Share by Company (2017-2022)
Table 52. North America Diabetes Devices Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Diabetes Devices Revenue Market Share by Company (2017-2022)
Table 54. North America Diabetes Devices Sales by Type (2017-2022) & (K Units)
Table 55. North America Diabetes Devices Sales by Type (2023-2028) & (K Units)
Table 56. North America Diabetes Devices Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Diabetes Devices Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Diabetes Devices Sales by Application (2017-2022) & (K Units)
Table 59. North America Diabetes Devices Sales by Application (2023-2028) & (K Units)
Table 60. North America Diabetes Devices Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Diabetes Devices Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Diabetes Devices Sales by Country (2017-2022) & (K Units)
Table 63. North America Diabetes Devices Sales by Country (2023-2028) & (K Units)
Table 64. North America Diabetes Devices Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Diabetes Devices Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Diabetes Devices Sales by Company (2017-2022) & (K Units)
Table 67. Europe Diabetes Devices Sales Market Share by Company (2017-2022)
Table 68. Europe Diabetes Devices Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Diabetes Devices Revenue Market Share by Company (2017-2022)
Table 70. Europe Diabetes Devices Sales by Type (2017-2022) & (K Units)
Table 71. Europe Diabetes Devices Sales by Type (2023-2028) & (K Units)
Table 72. Europe Diabetes Devices Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Diabetes Devices Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Diabetes Devices Sales by Application (2017-2022) & (K Units)
Table 75. Europe Diabetes Devices Sales by Application (2023-2028) & (K Units)
Table 76. Europe Diabetes Devices Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Diabetes Devices Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Diabetes Devices Sales by Country (2017-2022) & (K Units)
Table 79. Europe Diabetes Devices Sales by Country (2023-2028) & (K Units)
Table 80. Europe Diabetes Devices Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Diabetes Devices Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Diabetes Devices Sales by Company (2017-2022) & (K Units)
Table 83. Asia Pacific Diabetes Devices Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Diabetes Devices Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Diabetes Devices Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Diabetes Devices Sales by Type (2017-2022) & (K Units)
Table 87. Asia Pacific Diabetes Devices Sales by Type (2023-2028) & (K Units)
Table 88. Asia Pacific Diabetes Devices Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Diabetes Devices Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Diabetes Devices Sales by Application (2017-2022) & (K Units)
Table 91. Asia Pacific Diabetes Devices Sales by Application (2023-2028) & (K Units)
Table 92. Asia Pacific Diabetes Devices Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Diabetes Devices Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Diabetes Devices Sales by Region (2017-2022) & (K Units)
Table 95. Asia Pacific Diabetes Devices Sales by Region (2023-2028) & (K Units)
Table 96. Asia Pacific Diabetes Devices Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Diabetes Devices Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Diabetes Devices Sales by Company (2017-2022) & (K Units)
Table 99. Latin America Diabetes Devices Sales Market Share by Company (2017-2022)
Table 100. Latin America Diabetes Devices Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Diabetes Devices Revenue Market Share by Company (2017-2022)
Table 102. Latin America Diabetes Devices Sales by Type (2017-2022) & (K Units)
Table 103. Latin America Diabetes Devices Sales by Type (2023-2028) & (K Units)
Table 104. Latin America Diabetes Devices Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Diabetes Devices Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Diabetes Devices Sales by Application (2017-2022) & (K Units)
Table 107. Latin America Diabetes Devices Sales by Application (2023-2028) & (K Units)
Table 108. Latin America Diabetes Devices Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Diabetes Devices Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Diabetes Devices Sales by Country (2017-2022) & (K Units)
Table 111. Latin America Diabetes Devices Sales by Country (2023-2028) & (K Units)
Table 112. Latin America Diabetes Devices Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Diabetes Devices Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Diabetes Devices Sales by Company (2017-2022) & (K Units)
Table 115. Middle East and Africa Diabetes Devices Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Diabetes Devices Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Diabetes Devices Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Diabetes Devices Sales by Type (2017-2022) & (K Units)
Table 119. Middle East and Africa Diabetes Devices Sales by Type (2023-2028) & (K Units)
Table 120. Middle East and Africa Diabetes Devices Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Diabetes Devices Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Diabetes Devices Sales by Application (2017-2022) & (K Units)
Table 123. Middle East and Africa Diabetes Devices Sales by Application (2023-2028) & (K Units)
Table 124. Middle East and Africa Diabetes Devices Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Diabetes Devices Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Diabetes Devices Sales by Country (2017-2022) & (K Units)
Table 127. Middle East and Africa Diabetes Devices Sales by Country (2023-2028) & (K Units)
Table 128. Middle East and Africa Diabetes Devices Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Diabetes Devices Revenue by Country (2023-2028) & (US$ Million)
Table 130. Medtronic Corporation Information
Table 131. Medtronic Description and Overview
Table 132. Medtronic Diabetes Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 133. Medtronic Diabetes Devices Product and Services
Table 134. Medtronic Diabetes Devices SWOT Analysis
Table 135. Medtronic Recent Developments
Table 136. Sanofi Corporation Information
Table 137. Sanofi Description and Overview
Table 138. Sanofi Diabetes Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 139. Sanofi Diabetes Devices Product and Services
Table 140. Sanofi Diabetes Devices SWOT Analysis
Table 141. Sanofi Recent Developments
Table 142. Bayer Corporation Information
Table 143. Bayer Description and Overview
Table 144. Bayer Diabetes Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 145. Bayer Diabetes Devices Product and Services
Table 146. Bayer Diabetes Devices SWOT Analysis
Table 147. Bayer Recent Developments
Table 148. Becton Corporation Information
Table 149. Becton Description and Overview
Table 150. Becton Diabetes Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 151. Becton Diabetes Devices Product and Services
Table 152. Becton Diabetes Devices SWOT Analysis
Table 153. Becton Recent Developments
Table 154. Dickinson and Company Corporation Information
Table 155. Dickinson and Company Description and Overview
Table 156. Dickinson and Company Diabetes Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 157. Dickinson and Company Diabetes Devices Product and Services
Table 158. Dickinson and Company Diabetes Devices SWOT Analysis
Table 159. Dickinson and Company Recent Developments
Table 160. Novo Nordisk Corporation Information
Table 161. Novo Nordisk Description and Overview
Table 162. Novo Nordisk Diabetes Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 163. Novo Nordisk Diabetes Devices Product and Services
Table 164. Novo Nordisk Diabetes Devices SWOT Analysis
Table 165. Novo Nordisk Recent Developments
Table 166. Abbott Laboratories Corporation Information
Table 167. Abbott Laboratories Description and Overview
Table 168. Abbott Laboratories Diabetes Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 169. Abbott Laboratories Diabetes Devices Product and Services
Table 170. Abbott Laboratories Diabetes Devices SWOT Analysis
Table 171. Abbott Laboratories Recent Developments
Table 172. Roche Corporation Information
Table 173. Roche Description and Overview
Table 174. Roche Diabetes Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 175. Roche Diabetes Devices Product and Services
Table 176. Roche Diabetes Devices SWOT Analysis
Table 177. Roche Recent Developments
Table 178. Lifescan Corporation Information
Table 179. Lifescan Description and Overview
Table 180. Lifescan Diabetes Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 181. Lifescan Diabetes Devices Product and Services
Table 182. Lifescan Diabetes Devices SWOT Analysis
Table 183. Lifescan Recent Developments
Table 184. B. Braun Corporation Information
Table 185. B. Braun Description and Overview
Table 186. B. Braun Diabetes Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 187. B. Braun Diabetes Devices Product and Services
Table 188. B. Braun Diabetes Devices SWOT Analysis
Table 189. B. Braun Recent Developments
Table 190. Dexcom Corporation Information
Table 191. Dexcom Description and Overview
Table 192. Dexcom Diabetes Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 193. Dexcom Diabetes Devices Product and Services
Table 194. Dexcom Recent Developments
Table 195. Ypsomed Holdings Corporation Information
Table 196. Ypsomed Holdings Description and Overview
Table 197. Ypsomed Holdings Diabetes Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 198. Ypsomed Holdings Diabetes Devices Product and Services
Table 199. Ypsomed Holdings Recent Developments
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Diabetes Devices Distributors List
Table 203. Diabetes Devices Customers List
Table 204. Research Programs/Design for This Report
Table 205. Key Data Information from Secondary Sources
Table 206. Key Data Information from Primary Sources
List of Figures
Figure 1. Diabetes Devices Product Picture
Figure 2. Global Diabetes Devices Sales Market Share by Type in 2021 & 2028
Figure 3. Blood Glucose Monitoring (BGM) Devices Product Picture
Figure 4. Insulin Delivery Devices Product Picture
Figure 5. Global Diabetes Devices Sales Market Share by Application in 2021 & 2028
Figure 6. Hospital Use Case
Figure 7. Personal Use Use Case
Figure 8. Clinic Use Case
Figure 9. Others Use Case
Figure 10. Diabetes Devices Report Years Considered
Figure 11. Global Diabetes Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Diabetes Devices Market Size 2017-2028 (US$ Million)
Figure 13. Global Diabetes Devices Sales (2017-2022) & (K Units)
Figure 14. Global Diabetes Devices Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Diabetes Devices Sales Market Share by Region (2017-2022)
Figure 16. Global Diabetes Devices Sales Market Share by Region in 2021
Figure 17. Global Diabetes Devices Revenue Market Share by Region in 2017 VS 2021
Figure 18. Global Diabetes Devices Sales Share by Manufacturers in 2021
Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Diabetes Devices Sales in 2021
Figure 20. Diabetes Devices Revenue Share by Manufacturers in 2021
Figure 21. Diabetes Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 22. Global Diabetes Devices Revenue Share by Type (2017-2022)
Figure 23. Global Diabetes Devices Revenue Growth Rate by Type in 2017 & 2021
Figure 24. Global Diabetes Devices Revenue Share by Application (2017-2022)
Figure 25.
  • Global Non-Invasive Glucose Meter Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 79
    This report studies The Non-Invasive Glucose Meter market. Noninvasive glucose monitoring refers to The measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from The disease) without drawing blood, puncturing The skin, or causing pain or trauma. The global Non-Invasive Glucose Meter market was valued at US$ 179.5 million in 2023 and is anticipated to reach US$ 271.2 million by 2030, witnessing a CAGR of 6.0% during The......
  • Global Glucose Meter Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 106
    Glucose Meter is a medical device for determining The approximate concentration of glucose in The blood. It can also be a strip of glucose paper dipped into a substance and measured to The glucose chart. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking The skin with a lancet, is placed on a disposable test strip that The meter reads and uses to calculate The blood glucose level. The meter the......
  • Global Blood Glucose Testing Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 101
    Blood glucose testing, also known as blood glucose monitoring, is one of The main tools involved in controlling diabetes. Blood glucose testing is The process used to measure The concentration of glucose in your blood. Blood glucose testing can be carried out at home using a blood glucose meter. A blood test involves pricking your finger with a small needle called a lancet, drawing a drop of blood from The finger and applying it to a test strip that has been engaged into a blood gluc......
  • Global Glucose Biosensors Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139
    According to our LPI (LP Information) latest study, the global Glucose Biosensors market size was valued at US$ 3249.7 million in 2023. With growing demand in downstream market, the Glucose Biosensors is forecast to a readjusted size of US$ 3620.7 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Glucose Biosensors market. Glucose Biosensors are expected to show stable growth in the future market. However, product ......
  • Global Artificial Pancreas Devices Systems Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Artificial Pancreas Devices Systems market size was valued at US$ 87 million in 2023. With growing demand in downstream market, the Artificial Pancreas Devices Systems is forecast to a readjusted size of US$ 199.2 million by 2030 with a CAGR of 12.6% during review period. The research report highlights the growth potential of the global Artificial Pancreas Devices Systems market. Artificial Pancreas Devices Systems are expect......
  • Global Blood Glucose Testing Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 130
    According to our LPI (LP Information) latest study, the global Blood Glucose Testing market size was valued at US$ 10710 million in 2023. With growing demand in downstream market, the Blood Glucose Testing is forecast to a readjusted size of US$ 13370 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Blood Glucose Testing market. Blood Glucose Testing are expected to show stable growth in the future market. However......
  • Global Lancing Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Lancing Devices market size was valued at US$ 315 million in 2023. With growing demand in downstream market, the Lancing Devices is forecast to a readjusted size of US$ 439.6 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Lancing Devices market. Lancing Devices are expected to show stable growth in the future market. However, product differentiation,......
  • Global Non-Invasive Glucose Meter Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Non-Invasive Glucose Meter market size was valued at US$ 175.6 million in 2023. With growing demand in downstream market, the Non-Invasive Glucose Meter is forecast to a readjusted size of US$ 268 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global Non-Invasive Glucose Meter market. Non-Invasive Glucose Meter are expected to show stable growth in the futu......
  • Global Glucose Meter Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Glucose Meter market size was valued at US$ 1258 million in 2023. With growing demand in downstream market, the Glucose Meter is forecast to a readjusted size of US$ 1959.5 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Glucose Meter market. Glucose Meter are expected to show stable growth in the future market. However, product differentiation, reduc......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs